Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/4628
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPaniz, A-
dc.contributor.authorStavropoulos, C-
dc.contributor.authorGelanew, T-
dc.contributor.authorLoucas, E-
dc.contributor.authorPerez, A-
dc.contributor.authorBenaím, Gustavo-
dc.contributor.authorPolsky, B-
dc.contributor.authorSchoenian, G-
dc.contributor.authorSordillo, E-
dc.date.accessioned2013-10-24T18:51:30Z-
dc.date.available2013-10-24T18:51:30Z-
dc.date.issued2011-04-
dc.identifier.citationVOL. 55, No. 4 pp. 1774–1776es_VE
dc.identifier.issn0066-4804-
dc.identifier.urihttp://hdl.handle.net/10872/4628-
dc.description.abstractOld World cutaneous leishmaniasis is a widespread and potentially disfiguring protozoal infection that is endemic in the Mediterranean basin, Africa, and parts of Asia. Human infection is caused by several species of Leishmania parasites, such as Leishmania infantum. Available systemic and topical treatments vary in efficacy and are often unjustified due to their toxicity. We report on a case that was treated with posaconazole, a drug typically considered an antifungal agent but which also targets specific metabolic pathways of the parasite.es_VE
dc.language.isoenes_VE
dc.publisherANTIMICROBIAL AGENTS AND CHEMOTHERAPYes_VE
dc.subjectcutaneous leishmaniasises_VE
dc.subjectprotozoal infection-
dc.titleSuccessful Treatment of Old World Cutaneous Leishmaniasis Caused by Leishmania infantum with Posaconazolees_VE
dc.typeArticlees_VE
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
Paniz et al. AAC 2011.pdf836.16 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.